Mathieu R Brodeur - JoVE Visualize

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

Arteriosclerosis, Thrombosis, and Vascular Biology|December 17, 2013

Evaluation of links between high-density lipoprotein genetics, functionality, and aortic valve stenosis risk in humansBenoit J Arsenault, Marie-Pierre Dubé, Mathieu R Brodeur, et al.

Circulation. Genomic and Precision Medicine|April 2, 2021

Role of Adenylate Cyclase 9 in the Pharmacogenomic Response to Dalcetrapib: Clinical Paradigm and Molecular Mechanisms in Precision Cardiovascular MedicineDavid Rhainds, Chris J Packard, Mathieu R Brodeur, et al.

Circulation|April 21, 2018

ADCY9 (Adenylate Cyclase Type 9) Inactivation Protects From Atherosclerosis Only in the Absence of CETP (Cholesteryl Ester Transfer Protein)Yohann Rautureau, Vanessa Deschambault, Marie-Ève Higgins, et al.

Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

Arteriosclerosis, Thrombosis, and Vascular Biology|December 17, 2013

Evaluation of links between high-density lipoprotein genetics, functionality, and aortic valve stenosis risk in humansBenoit J Arsenault, Marie-Pierre Dubé, Mathieu R Brodeur, et al.

Circulation. Genomic and Precision Medicine|April 2, 2021

Role of Adenylate Cyclase 9 in the Pharmacogenomic Response to Dalcetrapib: Clinical Paradigm and Molecular Mechanisms in Precision Cardiovascular MedicineDavid Rhainds, Chris J Packard, Mathieu R Brodeur, et al.

Circulation|April 21, 2018

ADCY9 (Adenylate Cyclase Type 9) Inactivation Protects From Atherosclerosis Only in the Absence of CETP (Cholesteryl Ester Transfer Protein)Yohann Rautureau, Vanessa Deschambault, Marie-Ève Higgins, et al.

Pageof 3